Tivorbex FDA Approval History
Tivorbex (indomethacin) is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of mild to moderate acute pain.
Development Timeline for Tivorbex
|Feb 25, 2014||Approval Iroko Pharmaceuticals Receives FDA Approval for Tivorbex|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.